ArticleEuropean heart journal. Cardiovascular pharmacotherapy2025

Design and baseline characteristics of the STRIDE trial: evaluating semaglutide in people with symptomatic peripheral artery disease and type 2 diabetes.

Marc P Bonaca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.